公开(公告)号：US20120217859A1

公开(公告)日：2012-08-30

申请号：US13092152

申请日：2011-04-22

Applicant: FENG-CHING SU

Inventor： FENG-CHING SU

IPC: A47B91/00 ,  F16M11/20

CPC classification number: H05K5/0234 ,  F16M2200/08 ,  H05K5/0204

Abstract: A housing includes a wall, a connector, a coupler, and a foot pad. The housing includes a bottom surface, a recess defined in the bottom surface, and a discontinuous ring-shaped engagement member surrounding the recess. The engagement member has a first gap and a second gap aligned with the first gap. The connector is connected to the engagement member and is rotatably engaged in the first gap. The coupler includes a main body and an engagement portion extending from a circumference surface thereof. A first engagement hole defined in a central portion of the main body. The main body is rotatably connected to the connector and engagable in the recess. The engagement portion engages in the second gap. The foot pad is connected to the coupler to seal the first engagement hole and received in the recess.

Abstract translation: 壳体包括壁，连接器，耦合器和脚垫。 壳体包括底表面，限定在底表面中的凹部和围绕凹部的不连续的环形接合构件。 接合构件具有与第一间隙对准的第一间隙和第二间隙。 连接器连接到接合构件并且可旋转地接合在第一间隙中。 耦合器包括主体和从其圆周表面延伸的接合部分。 第一接合孔，限定在主体的中心部分。 主体可旋转地连接到连接器并且可接合在凹部中。 接合部分啮合在第二间隙中。 脚垫连接到联接器以密封第一接合孔并且容纳在凹部中。

公开(公告)号：US20120183504A1

公开(公告)日：2012-07-19

申请号：US13006432

申请日：2011-01-14

Applicant: Ying-Chen LU ,  Jau-Shyang HUANG ,  Feng-Ching HSIEH ,  Yi-Cheng LI ,  Chia-Lin LEE

Inventor： Ying-Chen LU ,  Jau-Shyang HUANG ,  Feng-Ching HSIEH ,  Yi-Cheng LI ,  Chia-Lin LEE

IPC: A61K35/74 ,  A61P13/12 ,  A61P3/10

CPC classification number: A61K35/747 ,  A61K35/745 ,  A61K2300/00

Abstract: A use of probiotic strain GM-263 (ADR-1) in treating renal fibrosis in diabetes is disclosed. The probiotic strain such as Lactobacillus renteri strain GM-263 (ADR-1) (accession No. CCTCC M 209263) is utilized to produce a composition for treating renal fibrosis in diabetes in an effective dose, thereby reducing the concentration of glycated hemoglobin and blood sugar and keeping body weight and kidney weight within normal range, as well as specifically inhibiting phosphorylation of JAK2/STAT1 signal transduction pathway and renal fibrosis-related protein expression.

Abstract translation: 公开了益生菌菌株GM-263（ADR-1）在治疗糖尿病肾纤维化中的应用。 益生菌菌株如转基因乳杆菌菌株GM-263（ADR-1）（登录号CCTCC M 209263）用于产生有效剂量治疗糖尿病肾纤维化的组合物，从而降低糖化血红蛋白和血液的浓度 糖和保持体重和肾脏重量在正常范围内，以及特异性抑制JAK2 / STAT1信号转导通路和肾纤维化相关蛋白表达的磷酸化。

公开(公告)号：US20120052047A1

公开(公告)日：2012-03-01

申请号：US12947829

申请日：2010-11-17

Applicant: Ying-Chen LU ,  Feng-Ching HSIEH ,  Cheng-Chih TSAI ,  Chih-Yang HUANG ,  Hsueh-Fang WANG ,  Chien-Yu TSENG

Inventor： Ying-Chen LU ,  Feng-Ching HSIEH ,  Cheng-Chih TSAI ,  Chih-Yang HUANG ,  Hsueh-Fang WANG ,  Chien-Yu TSENG

IPC: A61K35/74 ,  A61P9/00

CPC classification number: A61K35/747 ,  A23L33/135 ,  A23V2002/00 ,  A23Y2220/63 ,  A61K2035/115 ,  C12N1/20 ,  C12R1/225 ,  A23V2200/3204 ,  A23V2200/326

Abstract: A use of probiotic strain GM-080 in treating cardiac inflammation and apoptosis is disclosed. The probiotic strain GM-080 such as Lactobacillus paracasei strain GM-080 (accession No. CCTCC M 204012) is utilized to produce a composition for treating cardiac inflammation and apoptosis in an effective dose.

Abstract translation: 公开了益生菌菌株GM-080在治疗心脏炎症和细胞凋亡中的应用。 利用益生菌菌株GM-080，例如副干酪乳杆菌菌株GM-080（登录号CCTCC M 204012）产生有效剂量治疗心脏炎症和细胞凋亡的组合物。

公开(公告)号：US20090274672A1

公开(公告)日：2009-11-05

申请号：US12340081

申请日：2008-12-19

Applicant: Tu-Wen Yu ,  Jun-Sheng Li ,  Feng-Ching Hsieh ,  Ching-Pei Chen ,  Tsuei-Yin Huang ,  Ying-Chen Lu

Inventor： Tu-Wen Yu ,  Jun-Sheng Li ,  Feng-Ching Hsieh ,  Ching-Pei Chen ,  Tsuei-Yin Huang ,  Ying-Chen Lu

IPC: A61K35/74 ,  C12N1/20 ,  A23L1/48

CPC classification number: C12R1/225 ,  A23L33/135 ,  A23V2002/00 ,  A23Y2220/77 ,  A61K35/747 ,  C12N1/20 ,  Y10S435/853 ,  A23V2200/3204

Abstract: Disclosed herein are two Lactobacillus isolates having anti-inflammatory activities and beneficial probiotic properties, i.e., Lactobacillus sakei GMNL-76 and Lactobacillus reuteri GMNL-89, which were deposited in the Biosource Collection and Research Center (BCRC) of the Food Industry Research and Development Institute (FIRDI) under accession numbers BCRC 910355 and BCRC 910340 and in the China Center for Type Culture Collection (CCTCC) under accession numbers CCTCC M 207153 and CCTCC M 207154, respectively. The two Lactobacillus isolates and their sub-cultured offspring can be used in the preparation of a variety of food products, and in the manufacture of pharmaceutical compositions for treating and/or alleviating diseases associated with inflammation, such as rheumatoid arthritis.

Abstract translation: 本文公开了两种具有抗炎活性和有益益生菌特性的分离乳杆菌的乳酸杆菌GMNL-76和赖氨酸乳杆菌GMNL-89，其保藏在食品工业研究与开发的生物源收集和研究中心（BCRC）中 研究所（FIRDI）分别以登记号BCRC 910355和BCRC 910340以及中国类型培养物保藏中心（CCTCC），登录号为CCTCC M 207153和CCTCC M 207154。 两种乳酸杆菌分离物及其亚培养的后代可用于制备各种食品，以及用于制备用于治疗和/或减轻与炎症相关的疾病如类风湿性关节炎的药物组合物。

公开(公告)号：US08753624B2

公开(公告)日：2014-06-17

申请号：US13273228

申请日：2011-10-14

Applicant: Ying-Chen Lu ,  Feng-Ching Hsieh

Inventor： Ying-Chen Lu ,  Feng-Ching Hsieh

IPC: A01N63/00

CPC classification number: A61K35/747 ,  A23L33/135 ,  A23V2002/00 ,  A23Y2220/63 ,  A61K35/744 ,  A61K35/745 ,  C12N1/20 ,  C12R1/225 ,  A61K2300/00 ,  A23V2200/304 ,  A23V2200/3204

Abstract: An isolated Lactobacillus paracasei strain GMNL-133 is disclosed, which was deposited in the China Center for Type Culture Collection (CCTCC) under the accession number of CCTCC M 2011331 is disclosed. The isolated Lactobacillus paracasei strain GMNL-133 is used for preparing a composition for use in the treatment of atopic dermatitis or other allergic diseases in an effective amount. And a composition for use in the treatment of atopic dermatitis or other allergic diseases comprises an effective amount of the Lactobacillus paracasei strain GMNL-133 is also disclosed.

Abstract translation: 公开了一种孤立的副干酪乳杆菌菌株GMNL-133，该菌株以CCTCC M 2011331的保藏号存于中国型号培养物保藏中心（CCTCC）。 分离的副干酪乳杆菌菌株GMNL-133用于制备用于治疗特应性皮炎或其他有效量的过敏性疾病的组合物。 并且用于治疗特应性皮炎或其它过敏性疾病的组合物还包括有效量的副干酪乳杆菌菌株GMNL-133。

公开(公告)号：US08376557B2

公开(公告)日：2013-02-19

申请号：US13092152

申请日：2011-04-22

Applicant: Feng-Ching Su

Inventor： Feng-Ching Su

IPC: A47B91/00 ,  F16M11/20 ,  B65D51/18 ,  G06F1/16 ,  H05K5/00 ,  H05K7/00 ,  G03B21/14 ,  G03B21/22 ,  B65D47/00 ,  B67D3/00

CPC classification number: H05K5/0234 ,  F16M2200/08 ,  H05K5/0204

Abstract: A housing includes a wall, a connector, a coupler, and a foot pad. The housing includes a bottom surface, a recess defined in the bottom surface, and a discontinuous ring-shaped engagement member surrounding the recess. The engagement member has a first gap and a second gap aligned with the first gap. The connector is connected to the engagement member and is rotatably engaged in the first gap. The coupler includes a main body and an engagement portion extending from a circumference surface thereof. A first engagement hole defined in a central portion of the main body. The main body is rotatably connected to the connector and engagable in the recess. The engagement portion engages in the second gap. The foot pad is connected to the coupler to seal the first engagement hole and received in the recess.

Abstract translation: 壳体包括壁，连接器，耦合器和脚垫。 壳体包括底表面，限定在底表面中的凹部和围绕凹部的不连续的环形接合构件。 接合构件具有与第一间隙对准的第一间隙和第二间隙。 连接器连接到接合构件并且可旋转地接合在第一间隙中。 耦合器包括主体和从其圆周表面延伸的接合部分。 第一接合孔，限定在主体的中心部分。 主体可旋转地连接到连接器并且可接合在凹部中。 接合部分啮合在第二间隙中。 脚垫连接到联接器以密封第一接合孔并且容纳在凹部中。

公开(公告)号：US20110300117A1

公开(公告)日：2011-12-08

申请号：US12792276

申请日：2010-06-02

Applicant: Ying-Chen Leu ,  Feng-Ching Hsieh

Inventor： Ying-Chen Leu ,  Feng-Ching Hsieh

IPC: A61K35/74 ,  C12N1/20 ,  A61P3/10

CPC classification number: C12R1/225 ,  A61K2035/115 ,  C12N1/20

Abstract: The invention relates to a composition for improving the syndrome of diabetes and complication thereof. The composition comprises an effective amount of Lactobacillus strain which is at least one selected from the group consisting of: Lactobacillus reuteri GMNL-89 strain, Lactobacillus gasseri GMNL-205 strain, Lactobacillus reuteri GMNL-263 strain and a pharmaceutical acceptable vehicle. The Lactobacillus gasseri GMNL-205 strain and Lactobacillus reuteri GMNL-263 strain are novel isolated Lactobacillus strains. In addition, the invention also relates to a novel use of the composition or the Lactobacillus strains for improving the syndrome of diabetes and complication thereof.

Abstract translation: 本发明涉及一种改善糖尿病综合征及其并发症的组合物。 组合物包含有效量的乳杆菌属菌株，其为选自由以下的至少一种：罗伊氏乳杆菌GMNL-89菌株，加氏乳杆菌GMNL-205菌株，罗伊氏乳杆菌GMNL-263菌株和药学上可接受的载体。 加氏乳杆菌GMNL-205菌株和罗伊氏乳杆菌GMNL-263株是新型分离的乳杆菌属菌株。 此外，本发明还涉及组合物或乳杆菌属菌株用于改善糖尿病综合征及其并发症的新用途。

公开(公告)号：US6162850A

公开(公告)日：2000-12-19

申请号：US936256

申请日：1997-09-24

Applicant: Steve Boucher ,  Paul Whyzmuzis, deceased ,  Brenda Taipale ,  George A Smith ,  Joseph Sinka ,  Feng Ching

Inventor： Steve Boucher ,  Paul Whyzmuzis, deceased ,  Brenda Taipale ,  George A Smith ,  Joseph Sinka ,  Feng Ching

IPC: C08F220/18 ,  C08J3/10 ,  C08K3/38 ,  C08K5/55

CPC classification number: C08F220/18

Abstract: The invention is high temperature emulsion composition comprising borax and a substantially water-insoluble polymer prepared by aqueous suspension polymerizing a blend of monomers, said blend comprising a plasticizing amount by weight of at least one plasticizing alkyl acrylate monomer, a hardening amount by weight of at least one hardening alkyl acrylate monomer and a crosslinking amount by weight of at least one multi-ethylenically unsaturated monomer, in an aqueous suspension comprising a water-soluble polymer component comprising at least one acrylic polymer having carboxylate functionality, its method of use and coated substrates made therewith.

公开(公告)号：US20210031027A1

公开(公告)日：2021-02-04

申请号：US17072559

申请日：2020-10-16

Applicant: Feng Ching TU

Inventor： Feng Ching TU

IPC: A61N1/04 ,  B26D7/26 ,  B26F1/44

Abstract: A shape cutting device of a skin electrode patch includes: a substrate conveyor for transmitting a coated substrate portion and a conductive adhesive portion; a positioning conveyor; a fitted shape cutting module installed in a successive portion of the positioning conveyor and having two pressing wheels and a shape cutting unit, and the two pressing wheels being provided for pressing the coated substrate portion and the conductive adhesive portion, and the shape cutting unit including a roller body with at least one cutting knife which is in a geometrical shape and includes two side cutters and a first-end cutter at an axial end, and opposite ends of the first-end cutter having two second-end cutters, and a gap being formed in the two second-end cutters. The cutting knife has a design that integrates the transmission feature and the efficiency of the whole production line.

公开(公告)号：US20180141231A1

公开(公告)日：2018-05-24

申请号：US15357088

申请日：2016-11-21

Applicant: FENG CHING TU

Inventor： FENG CHING TU

IPC: B26F1/38 ,  A61N1/04 ,  B26D7/06

CPC classification number: B26F1/384 ,  A61N1/0492 ,  B26D7/0625

Abstract: A shape cutting device of a skin electrode patch includes: a substrate conveyor for transmitting a coated substrate portion and a conductive adhesive portion; a positioning conveyor; a fitted shape cutting module installed in a successive portion of the positioning conveyor and having two pressing wheels and a shape cutting unit, and the two pressing wheels being provided for pressing the coated substrate portion and the conductive adhesive portion, and the shape cutting unit including a roller body with at least one cutting knife which is in a geometrical shape and includes two side cutters and a first-end cutter at an axial end, and opposite ends of the first-end cutter having two second-end cutters, and a gap being formed in the two second-end cutters. The cutting knife has a design that integrates the transmission feature and the efficiency of the whole production line.